Immunotherapy that leverages HPV-specific immune responses for precancer lesions of cervical cancer

Immunotherapy that leverages HPV-specific immune responses for precancer lesions of cervical cancer

Cervical cancer and its precursor lesion, cervical intraepithelial neoplasia (CIN), are caused by high-risk human papillomavirus (HPV) viral infection and are highly susceptible to host immunity targeting of HPV viral proteins, which include both foreign antigens and cancer antigens expressed by tum...

Full description

Bibliographic Details
Main Authors: Osamu Kobayashi, Ayumi Taguchi, Takahiro Nakajima, Yuji Ikeda, Keisuke Saito, Kei Kawana
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Therapeutic vaccine
Lactobacillus-based vaccine
Immunotherapy
Mucosal immunity
Cervical intraepithelial neoplasia (CIN)
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455923003005

Internet

http://www.sciencedirect.com/science/article/pii/S1028455923003005

Similar Items